Organigram Holdings Inc. EBITDA Margin

EBITDA Margin of OGI for past 10 years: annual, quarterly and twelve month trailing (TTM) including EBITDA Margin growth rates and interactive chart.


Highlights and Quick Summary

  • EBITDA Margin for the quarter ending February 28, 2022 was -26.44% (a -56.29% decrease compared to previous quarter)
  • Year-over-year quarterly EBITDA Margin decreased by -74.58%
  • Annual EBITDA Margin for 2021 was -103.18% (a -44.64% decrease from previous year)
  • Annual EBITDA Margin for 2020 was -186.37% (a 148.39% increase from previous year)
  • Annual EBITDA Margin for 2019 was -75.03% (a -21.61% decrease from previous year)
  • Twelve month EBITDA Margin ending February 28, 2022 was -51.23% (a -40.37% decrease compared to previous quarter)
  • Twelve month trailing EBITDA Margin decreased by -66.74% year-over-year
Trailing EBITDA Margin for the last four month:
28 Feb '22 30 Nov '21 31 Aug '21 31 May '21
-51.23% -85.91% -103.17% -154.01%
Visit stockrow.com/OGI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EBITDA Margin of Organigram Holdings Inc.

Most recent EBITDA Marginof OGI including historical data for past 10 years.

Interactive Chart of EBITDA Margin of Organigram Holdings Inc.

Organigram Holdings Inc. EBITDA Margin for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 -26.44%
2021 -60.49% -26.64% -104.03% -212.26% -103.18%
2020 -118.69% -199.36% -526.0% 1.3% -186.37%
2019 13.97% -152.31% -36.81% 0.0% -75.03%
2018 385.37% 100.0% -95.71%
2017 -151.72%
2016 28.5%

Business Profile of Organigram Holdings Inc.

Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic